<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1811">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05137587</url>
  </required_header>
  <id_info>
    <org_study_id>09.2021.497</org_study_id>
    <nct_id>NCT05137587</nct_id>
  </id_info>
  <brief_title>Importance of Integrated Pulmonary Index in Pediatric Bronchoscopy</brief_title>
  <official_title>Importance of Integrated Pulmonary Index in Pediatric Patients Undergoing Bronchoscopy Procedures Under Sedation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marmara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marmara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Integrated Pulmonary Index (IPI) is a tool that provides numerical values on a scale of 1-10&#xD;
      based on physiological parameters such as peripheral oxygen saturation (SpO2), pulse rate,&#xD;
      respiratory rate, end-tidal carbon dioxide (ETCO2). It is a valuable monitor for sedation&#xD;
      procedures and can provide early warning during cardiorespiratory derangements. In this&#xD;
      study, we wanted to evaluate the value of IPI in cases of pediatric bronchoscopy performed&#xD;
      under sedation. Our outcome measure will be the correlation of IPI values with standard&#xD;
      monitoring parameters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bronchoscopy is a procedure that is frequently applied in diagnostic or interventional&#xD;
      conditions like hemoptysis, tracheobronchial stenosis, malignancy, recurrent lung infections,&#xD;
      etc. It is routinely performed under general anesthesia or sedation in pediatric cases. In&#xD;
      our clinic, we routinely perform diagnostic or interventional pediatric bronchoscopy&#xD;
      procedures with an anesthesia team outside the operating room under monitored anesthetic care&#xD;
      (MAC). Routine monitoring of MAC consists of electrocardiography (ECG), non-invasive blood&#xD;
      pressure (NIBP), and peripheral oxygen saturation (SpO2). These monitorizations are described&#xD;
      as minimum in many practice guidelines, and sometimes monitors such as end-tidal carbon&#xD;
      dioxide (ETCO2), body temperature, analgesia/nociception index (ANI) can be added to them.&#xD;
&#xD;
      Integrated Pulmonary Index (IPI) is a tool that provides numerical values on a scale of 1-10&#xD;
      based on physiological parameters such as peripheral oxygen saturation (SpO2), pulse rate,&#xD;
      respiratory rate, end-tidal carbon dioxide (ETCO2).(1,2) When these parameters exceed&#xD;
      physiological limits, patients require interventions consisting of various maneuvers or drug&#xD;
      administration in order to maintain the normal functioning of the cardiorespiratory system.&#xD;
      If we look at the scoring, a score of 8-10 is considered normal, a score of 5-7 indicates a&#xD;
      situation that may require intervention, and a score of 1-4 indicates that the patient needs&#xD;
      intervention.&#xD;
&#xD;
      The above-mentioned IPI is a relatively new tool, and there is limited data in the literature&#xD;
      regarding its usability in patients undergoing interventional procedures under MAC.(3,4) In&#xD;
      this study, we wanted to evaluate the safety of IPI in cases of pediatric bronchoscopy&#xD;
      performed under sedation. Routine monitoring and drug applications for the procedure will be&#xD;
      in accordance with the institutional protocols, and additional IPI monitoring will be&#xD;
      performed. Our outcome measure will be the correlation of IPI values with standard monitoring&#xD;
      parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IPI-Ketamine</measure>
    <time_frame>Throughout the sedation procedure</time_frame>
    <description>Correlation of ketamine and IPI values</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Monitored Anesthesia Care</condition>
  <condition>Respiratory Monitoring</condition>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients sedated with propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group K</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients sedated with ketamine</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Integrated Pulmonary Index (IPI) monitoring</intervention_name>
    <description>Integrated Pulmonary Index (IPI) monitor will be applied to the patients, to provide numerical data obtained from the measurements of end-tidal carbon dioxide, respiratory rate, oxygen saturation measured by pulse oximetry (SpO2), and pulse rate.</description>
    <arm_group_label>Group K</arm_group_label>
    <arm_group_label>Group P</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol</description>
    <arm_group_label>Group P</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine</intervention_name>
    <description>ketamine</description>
    <arm_group_label>Group K</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA 1-3 physical status&#xD;
&#xD;
          -  Elective upper or lower gastrointestinal tract endoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA physical status of 4 or more&#xD;
&#xD;
          -  Patients with any contraindication for off-site anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruslan Abdullayev</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University Department of Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruslan Abdullayev</last_name>
    <phone>+905063010833</phone>
    <email>ruslan_jnr@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yavuz Kelleci</last_name>
    <email>dryavuzk@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marmara University School of Medicine</name>
      <address>
        <city>Istanbul</city>
        <state>Pendik</state>
        <zip>34899</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruslan Abdullayev</last_name>
      <phone>+905063010833</phone>
      <email>ruslan_jnr@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Taft A, Ronen M, Epps C, Waugh J, Wales R. A Novel Integrated Pulmonary Index (IPI) quantifies heart rate, etCO2, respiratory rate and SpO2%. ASA A1682, 22 Oct 2008.</citation>
  </reference>
  <reference>
    <citation>Berkenstadt H, Ben-Menachem E, Herman A, Dach R. An evaluation of the Integrated Pulmonary Index (IPI) for the detection of respiratory events in sedated patients undergoing colonoscopy. J Clin Monit Comput. 2012 Jun;26(3):177-81. doi: 10.1007/s10877-012-9357-x. Epub 2012 Mar 28.</citation>
    <PMID>22454276</PMID>
  </reference>
  <reference>
    <citation>Riphaus A, Wehrmann T, Kronshage T, Geist C, Pox CP, Heringlake S, Schmiegel W, Beitz A, Meining A, Müller M, von Delius S. Clinical value of the Integrated Pulmonary Index(®) during sedation for interventional upper GI-endoscopy: A randomized, prospective tri-center study. Dig Liver Dis. 2017 Jan;49(1):45-49. doi: 10.1016/j.dld.2016.08.124. Epub 2016 Sep 1.</citation>
    <PMID>27671621</PMID>
  </reference>
  <reference>
    <citation>Garah J, Adiv OE, Rosen I, Shaoul R. The value of Integrated Pulmonary Index (IPI) monitoring during endoscopies in children. J Clin Monit Comput. 2015 Dec;29(6):773-8. doi: 10.1007/s10877-015-9665-z. Epub 2015 Feb 11.</citation>
    <PMID>25666393</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 25, 2021</study_first_submitted>
  <study_first_submitted_qc>November 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2021</study_first_posted>
  <last_update_submitted>November 27, 2021</last_update_submitted>
  <last_update_submitted_qc>November 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Marmara University</investigator_affiliation>
    <investigator_full_name>Ruslan Abdullayev</investigator_full_name>
    <investigator_title>Assist. Prof.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

